1 Department of Virology, United States Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
2 Division of General Communicable Diseases, Department of Communicable Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
3 Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, MA.
4 Department of Virus Diseases, Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Silver Spring, MD.
Received for publication October 1, 2001; accepted for publication February 25, 2002.
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
dengue hemorrhagic fever; dengue virus; disease attributes; epidemiologic factors; infection; serotyping
Abbreviations: Abbreviations: EIA, enzyme immunoassay; HAI, hemagglutination inhibition; Ig, immunoglobulin; PRNT, plaque reduction neutralization titer.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Dengue has emerged as a global health problem, as evidenced by a series of epidemics throughout the tropical and subtropical regions of the world (7). DEN-2 was present in the Americas during the 1970s, and DEN-1 was introduced in 1977, DEN-4 in 1981, and DEN-3 in 1994 (7). The propensity of specific dengue serotypes to produce more severe disease was initially observed by Siler and Simmons during human clinical studies on dengue infection (8, 9).
Few studies have examined the long-term circulation of dengue serotypes in one population over time and their capacity to induce epidemics or severe dengue disease (10, 11). The Prospective Study of Dengue Virus Infection in Primary School Children in Kamphaeng Phet, Thailand, is a prospective cohort study designed to answer these and other fundamental questions about why children develop severe dengue disease. This study, initiated in January 1998, follows approximately 2,200 primary school children from grades 2 through 6 for development of subclinical or severe dengue disease. In this paper, we report data from the first 3 years of this study (19982000) on the circulation of dengue serotypes within this population over time and their association with severe dengue disease.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Study site
The study site and field laboratory have been described previously (13, 14). Briefly, the site is located in the province of Kamphaeng Phet, an agrarian area of 8,608 km2 located approximately 358 km northwest of Bangkok, Thailand. This study is being conducted in subdistrict Muang, which, according to the year 2000 census, has a population of 198,943 and 49,593 households.
Study design
Children were enrolled from 12 elementary schools in the district (figure 1). Baseline demographic information, height and weight, and a blood sample for plasma and peripheral blood mononuclear cells were obtained every January to evaluate participating students. Each year, all participants were evaluated on June 1, August 15, and November 15, when a blood sample was obtained for dengue serology. Case surveillance of study participants for active acute illness occurred from June 1 to November 15, the peak dengue transmission season in Thailand.
|
Laboratory assays
Details regarding serologic assays are being reported separately (12). Hemagglutination inhibition (HAI) assays and antidengue immunoglobulin (Ig)M/IgG enzyme immunoassays (EIA) were performed as described previously (15, 16). Plaque reduction neutralization titers (PRNT) against DEN-1, DEN-2, DEN-3, and DEN-4 were measured by using the method of Russell et al. (17) and Yuill et al. (18). Japanese encephalitis infection as a source of dengue antibody cross-reactivity was excluded by performing Japanese encephalitis-specific HAI assay and IgM/IgG by EIA concurrently with all test sera.
Virus isolation and typing EIA to identify dengue serotypes
Dengue viruses were isolated in Toxorhynchites splendens mosquitoes, as described previously, and were amplified in C6/36 cell cultures (19). Dengue serotypes were identified by using an antigen-capture EIA, also described previously (20, 21).
Detection of dengue virus RNA by reverse-transcriptase polymerase chain reaction
Detection of dengue virus RNA and serotype identification were performed by using the Lanciotti procedure (22).
Serologic definitions of acute dengue virus infection
Dengue virus infection was defined as isolation of a dengue virus or detection of dengue virus RNA by reverse-transcriptase polymerase chain reaction from serum or plasma during an acute febrile illness, with serologic evidence of acute dengue infection. Dengue virus infection by serology was defined as a fourfold or greater rise in HAI antibody against any dengue virus serotype between the acute and convalescent specimens or in paired sera. Dengue virus-specific IgM levels of 40 units or more by IgM capture EIA were also considered diagnostic of an acute dengue virus infection. Primary dengue infection was defined, as described previously (16), as an acute dengue infection with an IgM-to-IgG ratio of 1.8 or greater by IgM capture EIA in the acute or convalescent specimen (16). A ratio of less than 1.8 was defined as an acute secondary dengue infection.
Clinical definitions of serologically confirmed dengue virus infection
Inapparent dengue virus infection
This condition was defined as a fourfold or greater rise in HAI antibody against any dengue virus serotype between paired sera obtained during the surveillance months (June, August, and November), without an associated febrile illness being identified.
Acute dengue fever
This condition was defined as a school absence of a child with a history of fever or fever on examination and serologic evidence of acute dengue virus infection with no evidence of dengue hemorrhagic fever according to World Health Organization criteria (23).
Acute dengue hemorrhagic fever and dengue hemorrhagic fever grade
These conditions were defined as a school absence of a child with a history of fever or fever on examination and serologic evidence of acute dengue virus infection with evidence of dengue hemorrhagic fever and dengue hemorrhagic fever grade according to World Health Organization criteria (23). Charts of hospitalized children are reviewed independently and their dengue illness determined to be either dengue fever or dengue hemorrhagic fever; if dengue hemorrhagic fever is identified, it is assigned a severity grade by an expert in the field (Dr. Suchitra Nimmannitya, Queen Sirikit National Institute of Child Health, Bangkok, Thailand).
Statistical analysis
Statistical analysis was performed by using SPSS software for Windows (version 10.0; SPSS Inc., Chicago, Illinois). Incidence rates were determined by using the total study population at the time of surveillance as the denominator. Students t test, analysis of variance, Pearsons correlation, or linear regression was used to determine differences or associations among continuous variables; chi-square tests were used for proportions.
Human use review and approval
The study protocol was reviewed and approved by the Human Use Review and Regulatory Agency of the Office of the Army Surgeon General, the Institutional Review Board of the University of Massachusetts School of Medicine, and the Thai Ethical Review Board of the Ministry of Public Health, Thailand.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Dengue virus infection
Incidence of dengue virus infection
The average incidence of dengue virus infection was 5.8 percent per 6-month period of observation during the dengue transmission season (henceforth referred to as per year), which was comprised of 3.1 percent per year of inapparent dengue infection and 2.7 percent per year of acute symptomatic dengue. The average incidence of symptomatic nonhospitalized dengue virus infection was 2.1 percent per year. The incidences of hospitalized dengue fever and hospitalized dengue hemorrhagic fever were 0.2 percent and 0.3 percent per year, respectively. Of the symptomatic cases of dengue infection, 3.9 percent were primary dengue virus infection and the remainder were secondary dengue infection. Dengue incidence varied by year. The incidence in 1998 was 7.9 percent, consisting of 4.3 percent inapparent dengue infection and 3.6 percent symptomatic dengue virus infection. In 1999, the incidence was 6.5 percent, consisting of 3.2 percent inapparent and 3.3 percent symptomatic dengue virus infection. The incidence in 2000 was 2.2 percent: 1.4 percent inapparent and 0.8 percent symptomatic dengue virus infection. Dengue incidence varied by school during each season and from year to year. Peak incidence occurred in school 4 (20.3 percent) during 1998, school 2 (12.8 percent) during 1999, and school 9 (11.5 percent) during 2000. School 1 was the only school with no evidence of dengue transmission during this 3-year period.
Population characteristics and dengue serotype-specific virus isolation
For the first 3 years of this study, a total of 167 children had an acute symptomatic dengue virus infection. Viral isolation was attempted from serum samples obtained from these children and yielded dengue viruses from 108 children; the viral isolation rate was 65 percent. DEN-3 was the most common serotype isolated (41 percent of all isolates), followed by DEN-2 (35 percent), DEN-1 (23 percent), and DEN-4 (1 percent) (table 1). No significant age or sex differences were noted between the groups infected with each serotype. Of the 108 children from whom a virus was isolated, three had primary dengue infections (two DEN-1 and one DEN-2), and the remainder had secondary dengue virus infections. None of the three subjects with symptomatic primary infections was hospitalized. Primary dengue in children may be milder than secondary dengue virus infections (24); therefore, these children were excluded from the analysis of dengue serotype and disease severity.
|
Spatial and temporal occurrence of dengue serotypes
Despite the geographic proximity of the schools in the study area (figure 1), occurrence of infection with each of the dengue serotypes clustered within schools and varied both spatially and temporally (figure 2). The majority of acute dengue infections and isolations occurred during June, July, and August each study year, corresponding to the peak dengue season.
|
All four dengue virus serotypes were isolated in 1999. DEN-2 was the predominant serotype (55 percent of isolates) and occurred in schools 24 and 912. DEN-1 was the next most frequently isolated serotype (33 percent) and was found in schools 69. DEN-3 comprised 12 percent of all viral isolates and occurred in schools 5, 6, and 12. Only one DEN-4 serotype was isolated from school 4. In schools 2, 3, 5, 7, 8, 10, and 11, only a single serotype was isolated. Two dengue serotypes were isolated during 1999 from children at each of four other schools. At schools 4 and 12, there were single isolates of each of two serotypes; at schools 6 and 9, DEN-1 predominated.
DEN-2 was the only dengue serotype isolated during 2000, a year in which dengue incidence was comparatively low. This serotype was isolated from schools 9 and 11.
Dengue incidence and preexisting dengue serotype-specific antibodies
The spatial and temporal diversity of detection of each dengue serotype within this well-defined population suggests that preexisting dengue serotype-specific antibodies may influence the circulation and occurrence of dengue virus serotypes and illness. For most schools that had a high incidence of infections with one dengue serotype, the same serotype was not detected the following year (data not shown). For example, school 4 experienced a large outbreak of DEN-3/DEN-1 in 1998 followed by DEN-2 and DEN-4 in 1999. Similarly, school 3 had a year with DEN-1 virus infections followed by DEN-2, and school 5 had DEN-2 and then DEN-3 infections. Schools 6 and 7 had an occurrence of DEN-1 and school 11 DEN-2 over 2 consecutive years, and dengue incidence declined each year.
To explore this pattern further, dengue serotype-specific HAI antibody titers were determined for each child prior to the dengue season during January of each year. The reciprocal geometric mean antibody titer by dengue virus serotype was 17 for DEN-1, 15 for DEN-2, 21 for DEN-3, 21 for DEN-4, and 15 for Japanese encephalitis. The population distribution of HAI antibody titers was also examined, and 90 percent of the population had a reciprocal antibody titer of 80 or less to each dengue virus serotype. We calculated the proportion of the population in each school with an HAI dengue serotype-specific antibody titer greater than 1/80 (10 percent of the population, approximately 45 times the reciprocal geometric mean titer) and looked for a correlation with dengue incidence by schools during the year. When we used Pearsons correlation or linear regression, no association was found between predengue-season population antibody and dengue incidence. School 1, for example, experienced no dengue virus infections during the 3 years of the study, although the proportion of students with high dengue HAI antibody levels was low. This finding suggests that serologic immunity was not the only factor influencing dengue transmission in a given school and that other factors not measured in this study, such as local environment and vector breeding, are also important determinants.
Disease severity by serotype-specific infection
Hospitalization rates per 100 dengue infections were determined for each study year and school. The hospitalization rate for acute dengue infection was 8.9 percent in 1998, 12.7 percent in 1999, and 2.7 percent in 2000 (p > 0.05 between years by chi-square test). The proportion of children hospitalized was 3/23 (13 percent) for DEN-1, 7/29 (24 percent) for DEN-2, and 14/44 (32 percent) for DEN-3. The proportion of children with dengue hemorrhagic fever was 2/23 (9 percent) for DEN-1, 4/29 (14 percent) for DEN-2, and 7/44 (16 percent) for DEN-3. A greater proportion of children with acute DEN-3 virus infection was hospitalized and developed dengue hemorrhagic fever than the other dengue virus serotypes, although these differences were not statistically significant (p > 0.05 by chi-square test).
Symptoms were elicited from each child with acute dengue virus infection on the first day of school absence. Symptom frequency as a marker of disease severity was determined for each dengue virus serotype. For all dengue serotypes, headache was the symptom reported most frequently. Headache, lethargy, and muscle pain were reported more frequently (84 percent, 40 percent, and 24 percent, respectively) by children with DEN-3 virus infection. Cough was reported more frequently in DEN-1 infections (56 percent).
For all children, dengue serotype-specific PRNT50 was determined in January (preillness), preceding acute dengue virus infection, to determine the sequence of infection with different dengue serotypes in primary and secondary infections (table 2). A monotypic PRNT50 pattern was evident for 29 of 108 children, enabling us to determine the sequence of infection based on the preillness serotype-specific antibody titer and the virus isolated during the secondary infection. Dengue hemorrhagic fever occurred during secondary infection in the following sequences: DEN-1DEN-3, DEN-2DEN-1, DEN-2DEN-3, and DEN-4DEN-2. None of the 12 children with symptomatic DEN-1 infection after primary DEN-4 infection required hospitalization (p < 0.05, Fishers exact test, two tailed compared with all other sequences).
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Understanding the epidemiology of how dengue virus serotypes circulate has important public health implications for understanding virus transmission, disease severity, vector control, and development of a safe and efficacious vaccine. Identifying the determinants of how dengue virus serotypes are circulated and transmitted in a population and their association with dengue disease severity will enable accurate models to be developed to predict dengue outbreaks of severe disease and to identify potential interventions by using vector control and a potential vaccine. Our results emphasize the need for a vaccine that includes all four dengue virus serotypes to induce protective immunity.
Much has been written about the spread of dengue virus throughout the subtropical and tropical areas of the world and the viruss potential to produce outbreaks and severe dengue disease (3, 24, 25). Previous studies that have examined the circulation of dengue serotypes in a well-defined population over time and the viruss capacity to produce localized outbreaks and severe dengue disease have demonstrated the importance of long-term, serotype-specific surveillance over time in understanding the pathogenesis of this virus (26, 27). In our own studies on the circulation of each dengue serotype in Thailand from 1973 to 1999, we have demonstrated that all four dengue serotypes circulate in any given year in both northern Thailand and Bangkok, with one serotype predominating as the cause of the outbreak (Nisalak et al., unpublished manuscript). Our localized population is a microcosm of the situation observed nationally and offers a different perspective on dengue virus circulation. In our population, one serotype emerges as the predominant dengue serotype in any given year as the cause of the outbreak. On closer inspection, this outbreak actually consists of many localized minioutbreaks of different dengue virus serotypes, with one dengue virus serotype emerging as the predominant virus.
Our study implies that most virus transmission occurs within the community or the schools. Occurrence of multiple dengue serotypes in a mobile society such as Thailand could also result from a serotype being introduced or an infection occurring in an urban area such as Bangkok or a nearby city that is then spread to a rural area such as Kamphaeng Phet. Previous studies have described the circulation of all four dengue serotypes within a population. Virus isolation in children with dengue hemorrhagic fever in Jakarta, Indonesia, demonstrated the temporal occurrence of all four dengue serotypes in an urban area, with DEN-3 as the predominant one (28). Early studies in Bangkok during the 1960s of children with dengue hemorrhagic fever also showed that all four dengue serotypes occurred (29, 30). The observation that some dengue virus strains produce more severe disease than others was inferred from experiments using human volunteers and from epidemiologic studies of dengue occurring in the Pacific Islands and Indonesia (4, 26, 31, 32). In addition, dengue viruses have been attenuated in the laboratory and used as experimental vaccines; several induced antibody and T-lymphocyte responses in human volunteers, with minimal reactogenicity (3335). Recently, DEN-2 strains of the Southeast Asian genotype have been found to be more pathogenic than the American genotype of DEN-2, providing a molecular basis from which to begin to understand some aspects of dengue virulence and pathogenicity (3638).
Our findings that hospitalization rates and symptom severity are greater for certain dengue serotypes are consistent with the current understanding of dengue virus biology, in that some strains and serotypes in combination with host determinants are more capable than others of producing more disease. These determinants include host and viral factors as well as the immunologic history of infection with other dengue serotypes. Secondary dengue is more severe than primary dengue and is associated with greater severity of constitutional symptoms as well as development of dengue hemorrhagic fever (39, 40). Immunologic history also relates to the sequence of dengue serotypes in primary and secondary infections. Previous studies in Thailand have reported that the sequence DEN-1DEN-2 resulted in a higher proportion of dengue hemorrhagic fever cases (11). However, in Indonesia, DEN-2 followed by DEN-1 resulted in severe disease (41). We found no cases with the DEN-1DEN-2 sequence. Of the four children with DEN-2DEN-1, one had dengue hemorrhagic fever. In contrast, none of the 12 children with the sequence DEN-4DEN-1 required hospitalization, implying that this sequence may induce a milder host immune response resulting in less severe dengue disease.
Our observations on the dengue sequence of infection should be kept in context because of difficulty in interpreting PRNTs and the effects of flavivirus antibody cross-reactivity on these titers. The sequences of infection and disease severity presented here are for children with clear monotypic titers to only one dengue serotype followed by the virus serotype determined by viral isolation. For the majority of children, preillness neutralizing titers were difficult to interpret for one dengue serotype, and information on these cases is not presented here.
Our preliminary results based on 3 years of surveillance provide observations on the complicated process involved in dengue virus circulation and the characteristics of each serotype with regard to producing severe dengue disease. Our findings emphasize the complexity of dengue virus transmission and pathogenicity involved in producing severe dengue disease. Our results emphasize the need for a dengue vaccine to prevent dengue illness, and they underscore the importance of developing a tetravalent vaccine as the most effective way to prevent dengue disease. Our study design provides the framework in which to evaluate the effectiveness of a tetravalent dengue vaccine in preventing severe dengue disease and in preventing transmission of dengue virus serotypes in a population.
![]() |
ACKNOWLEDGMENTS |
---|
The authors thank the staff at the Department of Virology, Armed Forces Research Institute of Medical Sciences (AFRIMS) for their carefully performed diagnostic testing, data collection, and data entry. They acknowledge the support of Dr. Choorat Koosakulrat and his staff, Office of the Provincial Public Health, Kamphaeng Phet Province, and the efforts of the clinical research nurses at AFRIMS and the support staff at the Kamphaeng Phet Field Station.
![]() |
NOTES |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|